resveratrol has been researched along with Brain Neoplasms in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (26.19) | 29.6817 |
| 2010's | 23 (54.76) | 24.3611 |
| 2020's | 8 (19.05) | 2.80 |
| Authors | Studies |
|---|---|
| Du, JZ; Lin, XM; Liu, J; Nie, JH; Shi, XX; Xiong, L; Ye, HS | 1 |
| Ahmad, Z; Akhtar, MF; Akter, R; Al-Shaeri, M; Ashraf, GM; Karthika, C; Khan, FS; Klepacka, J; Mondal, B; Najda, A; Rahman, MH; Ramproshad, S; Saleem, A; Tagde, P; Zehravi, M | 1 |
| Bagheri, H; Bahman, Y; Moliani, A; Mousavi, M; Zhang, Y; Zhang, Z | 1 |
| Ahmad, N; Cheng, X; Deng, S; Li, H; Shu, X; Song, D; Wang, Q; Wu, M; Xu, H; Yang, X | 1 |
| Aliashrafzadeh, H; Babaniamansour, S; Bahramvand, Y; Dianat-Moghadam, H; Jafarzadeh, E; Karkon-Shayan, S; Majidi, M; Moradi-Vastegani, S; Rastegar-Pouyani, N; Zarei, M | 1 |
| Andò, S; Chimento, A; Conforti, FL; D'Amico, M; De Amicis, F; Giordano, F; Malivindi, R; Montalto, FI; Panno, ML; Pezzi, V | 1 |
| Büsselberg, D; Kassayova, M; Kiskova, T; Kubatka, P | 1 |
| Allegretti, M; Bastioli, F; Covino, S; de Luca, A; Dionigi, L; Fioretti, B; Iannitti, RG; Monarca, L; Moulas, AN; Ragonese, F | 1 |
| Deshpande, P; Jhaveri, A; Pattni, B; Torchilin, V | 1 |
| Blasiak, J; Pawlowska, E; Szatkowska, M; Szczepanska, J | 1 |
| Bu, XY; Gao, YS; Han, SY; Hu, S; Qu, MQ; Wang, BQ; Wang, JY; Yan, ZY; Yang, B; Yang, HC | 1 |
| Agarwal, N; Bloom, L; Bregy, A; Gersey, Z; Komotar, RJ; Osiason, AD; Shah, S; Thompson, JW | 1 |
| Battastini, AM; Bernardi, A; Edelweiss, MI; Figueiró, F; Frozza, RL; Guterres, SS; Jandrey, EH; Moreira, JC; Pohlmann, AR; Salbego, CG; Terroso, T; Zanotto-Filho, A | 1 |
| Kayama, T; Kitanaka, C; Narita, Y; Okada, M; Sato, A; Seino, S; Shibui, S; Shibuya, K; Suzuki, K; Watanabe, E | 1 |
| Chen, XY; Gu, JY; Kong, QY; Li, H; Liu, J; Shi, S; Shu, XH; Song, X; Wang, LL; Wu, ML | 1 |
| Dai, F; Huang, Q; Jia, Z; Jiang, H; Kang, C; Pu, P; Wang, G; Yu, K; Zhang, A | 1 |
| Cui, J; Li, H; Overstreet, AM; Shan, D; Wang, Y; Xu, ZD; Xue, F; Yang, Y; Yu, C; Zhan, Y; Zhang, M | 1 |
| Barone, A; Jackson, E; Kim, AH; Leonard, JR; Marasa, J; Piwnica-Worms, D; Rao, S; Rubin, JB; Sengupta, R; Taylor, S; Warrington, NM | 1 |
| Cao, Y; Guo, A; Jiao, Y; Li, H; Li, Y; Liu, Y; Qu, X; Wang, S; Xu, X; Zhao, J | 1 |
| Cho, GJ; Choi, J; Choi, WS; Jeong, JY; Kang, S; Kang, SS; Kim, HJ; Lee, DH; Park, JW; Park, JY; Park, N; Roh, GS; Ryu, J; Seong, H; Yoon, NA | 1 |
| Balavigneswaran, CK; Mahto, SK; Mishra, N; Muthu, MS; Singh, S; Vajanthri, KY; Vijayakumar, MR | 1 |
| Bhattacharya, S; Clark, PA; Darjatmoko, SR; Elmayan, A; Kuo, JS; Polans, AS; Thuro, BA; van Ginkel, PR; Yan, MB | 1 |
| Bazzoni, R; Bentivegna, A; Butta, V; Cadamuro, M; Cilibrasi, C; Dalprà, L; Giovannoni, R; Lavitrano, M; Paoletta, L; Riva, G; Romano, G; Strazzabosco, M | 1 |
| Li, J; Liang, Z; Qin, Z | 1 |
| Aldini, G; Colombo, G; Colombo, R; Dalle-Donne, I; Gagliano, N; Gioia, M; Milzani, A; Rossi, R | 1 |
| Basso, E; Cornetta, T; Cozzi, R; Leone, S | 1 |
| Diah, S; Fei, Z; Kawai, N; Matsumoto, K; Miyake, K; Murao, K; Okada, M; Tamiya, T; Zhang, W; Zhang, X | 1 |
| Castino, R; Isidoro, C; Lah, TT; Morani, F; Peracchio, C; Pucer, A; Veneroni, R | 1 |
| Chang, CH; Chang, CJ; Chang, YL; Chen, MH; Chen, MT; Chiou, GY; Chiou, SH; Hsu, CC; Huang, PI; Ma, HI; Shih, YH; Tsai, LL; Tseng, LM; Wang, CT; Yang, YP; Yu, CC | 1 |
| Cheng, J; Huang, H; Lin, H; Liu, B; Xiong, W; Zhang, W; Zhang, X; Zhang, Y | 1 |
| Lee, CC; Lin, CJ; Lin, TY; Lin, YF; Shih, CM; Shih, YL; Wang, SH | 1 |
| Chen, XY; Kong, QY; Li, H; Liu, J; Shi, H; Shu, XH; Sun, Z; Wu, ML | 1 |
| Escher, F; Melzig, MF | 1 |
| Cavaletti, G; Miloso, M; Nicolini, G; Rigolio, R; Saccomanno, D; Scuteri, A; Tredici, G | 1 |
| Debatin, KM; Fulda, S | 1 |
| Miloso, M; Nicolini, G; Rigolio, R; Scuteri, A; Simone, M; Tredici, G; Villa, D | 1 |
| Chen, XY; Kong, QY; Li, H; Liu, J; Sun, Y; Wang, XW; Wen, S; Wu, ML; Zhang, P | 1 |
| Fei, Z; Zhang, JN; Zhang, W; Zhang, X; Zhen, HN | 1 |
| Davis, FB; Davis, PJ; Hammond, D; Hercbergs, A; Keating, T; Lin, HY; Shih, A; Sun, M; Tang, HY; Wu, YH | 1 |
| Cornetta, T; Cozzi, R; Fiore, M; Lauro, MG; Leone, S; Pino, S | 1 |
| Anker, A; Gülden, M; Maser, E; Rüweler, M; Seibert, H | 1 |
| Chen, XY; Kong, QY; Li, H; Liu, J; Liu, N; Wang, Q; Wu, ML; Zhang, KL | 1 |
7 review(s) available for resveratrol and Brain Neoplasms
| Article | Year |
|---|---|
Involvement of Resveratrol against Brain Cancer: A Combination Strategy with a Pharmaceutical Approach.
Topics: Antioxidants; Brain; Brain Neoplasms; Drug Delivery Systems; Humans; Pharmaceutical Preparations; Resveratrol; Stilbenes | 2022 |
Resveratrol as an antitumor agent for glioblastoma multiforme: Targeting resistance and promoting apoptotic cell deaths.
Topics: Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Humans; Phosphatidylinositol 3-Kinases; Resveratrol | 2023 |
The Plant-Derived Compound Resveratrol in Brain Cancer: A Review.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biological Availability; Brain; Brain Neoplasms; Drug Resistance, Neoplasm; Glioma; Humans; Resveratrol; Signal Transduction | 2020 |
Focus on the Use of Resveratrol as an Adjuvant in Glioblastoma Therapy.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Glioblastoma; Humans; Matrix Metalloproteinase 2; Phosphatidylinositol 3-Kinases; Resveratrol | 2020 |
An Interplay between Senescence, Apoptosis and Autophagy in Glioblastoma Multiforme-Role in Pathogenesis and Therapeutic Perspective.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Autophagy; Brain Neoplasms; Cellular Senescence; Dacarbazine; Disease Models, Animal; DNA Damage; Glioblastoma; Humans; Mice; Resveratrol; Stilbenes; Temozolomide | 2018 |
Therapeutic Targeting of the Notch Pathway in Glioblastoma Multiforme.
Topics: ADAM Proteins; Amyloid Precursor Protein Secretases; Antineoplastic Agents; Arsenic Trioxide; Brain Neoplasms; Cell Hypoxia; Cell Line, Tumor; Gene Knockdown Techniques; Glioblastoma; Humans; Inhibitor of Differentiation Proteins; Kruppel-Like Transcription Factors; MicroRNAs; Microvessels; Molecular Targeted Therapy; Neoplasm Proteins; Netrin-1; Niclosamide; Receptors, Notch; Receptors, Urokinase Plasminogen Activator; Resveratrol; Signal Transduction; Tretinoin | 2019 |
The potential of resveratrol against human gliomas.
Topics: Antineoplastic Agents; Brain Neoplasms; Glioma; Humans; Resveratrol; Ribonucleotide Reductases; Stilbenes | 2010 |
35 other study(ies) available for resveratrol and Brain Neoplasms
| Article | Year |
|---|---|
Construction of IL-13 Receptor α2-Targeting Resveratrol Nanoparticles against Glioblastoma Cells: Therapeutic Efficacy and Molecular Effects.
Topics: Animals; Apoptosis; Brain Neoplasms; Capsules; Cell Line, Tumor; Cell Proliferation; Drug Carriers; Drug Liberation; Glioblastoma; Humans; Interleukin-13 Receptor alpha2 Subunit; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Rats; Resveratrol; Treatment Outcome; Tumor Burden; Xenograft Model Antitumor Assays | 2021 |
Resveratrol inhibits glioblastoma cells and chemoresistance progression through blockade P-glycoprotein and targeting AKT/PTEN signaling pathway.
Topics: ATP Binding Cassette Transporter, Subfamily B; Brain Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Resistance, Neoplasm; Glioblastoma; Glioma; Humans; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Resveratrol; Signal Transduction | 2023 |
Resveratrol Enhances Temozolomide Efficacy in Glioblastoma Cells through Downregulated MGMT and Negative Regulators-Related STAT3 Inactivation.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Line, Tumor; DNA Modification Methylases; DNA Repair Enzymes; Drug Resistance, Neoplasm; Glioblastoma; Humans; Molecular Chaperones; Protein Inhibitors of Activated STAT; Resveratrol; STAT3 Transcription Factor; Suppressor of Cytokine Signaling Proteins; Temozolomide | 2023 |
Cdk4 Regulates Glioblastoma Cell Invasion and Stemness and Is Target of a Notch Inhibitor Plus Resveratrol Combined Treatment.
Topics: Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Glioblastoma; Humans; Neoplastic Stem Cells; Resveratrol; Signal Transduction | 2023 |
Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Survival; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Female; Glioblastoma; Humans; Liposomes; Mice; Mice, Nude; Receptors, Transferrin; Resveratrol; Treatment Outcome | 2018 |
Resveratrol restores sensitivity of glioma cells to temozolamide through inhibiting the activation of Wnt signaling pathway.
Topics: Animals; Apoptosis; Brain Neoplasms; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glioma; Glycogen Synthase Kinase 3 beta; Humans; Mice; Mice, Nude; O(6)-Methylguanine-DNA Methyltransferase; Resveratrol; Temozolomide; Wnt Signaling Pathway | 2019 |
Resveratrol-loaded lipid-core nanocapsules treatment reduces in vitro and in vivo glioma growth.
Topics: Animals; Apoptosis; Brain Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemical Phenomena; Chemistry, Pharmaceutical; Disease Models, Animal; G1 Phase; Glioma; Hippocampus; Humans; Lipids; Male; Nanocapsules; Neoplasm Transplantation; Rats; Rats, Wistar; Resveratrol; S Phase; Solutions; Stilbenes; Tumor Burden | 2013 |
Resveratrol promotes proteasome-dependent degradation of Nanog via p53 activation and induces differentiation of glioma stem cells.
Topics: Animals; Brain Neoplasms; Cell Differentiation; Cell Line, Tumor; Gene Silencing; Glioma; Homeodomain Proteins; Humans; Male; Mice; Mice, Inbred BALB C; Nanog Homeobox Protein; Neoplastic Stem Cells; Proteasome Endopeptidase Complex; Resveratrol; RNA, Small Interfering; Signal Transduction; Stilbenes; Transfection; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2013 |
Diffusion Efficiency and Bioavailability of Resveratrol Administered to Rat Brain by Different Routes: Therapeutic Implications.
Topics: Analysis of Variance; Animals; Anticarcinogenic Agents; Brain; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Glucuronosyltransferase; Male; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2015 |
Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Glioma; MicroRNAs; Rats; Resveratrol; Signal Transduction; Stilbenes; Xenograft Model Antitumor Assays | 2015 |
Resveratrol Represses Pokemon Expression in Human Glioma Cells.
Topics: Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cellular Senescence; DNA-Binding Proteins; DNA, Neoplasm; E1A-Associated p300 Protein; Gene Expression Regulation, Neoplastic; Glioma; HEK293 Cells; Histone Deacetylase 1; Humans; Promoter Regions, Genetic; Protein Binding; Protein Transport; Resveratrol; Sp1 Transcription Factor; Stilbenes; Transcription Factors | 2016 |
Novel chemical library screen identifies naturally occurring plant products that specifically disrupt glioblastoma-endothelial cell interactions.
Topics: Animals; Brain Neoplasms; Cell Communication; Cell Line, Tumor; Cells, Cultured; Coculture Techniques; Endothelial Cells; Female; Glioblastoma; Humans; Mice, Nude; Phytotherapy; Plant Extracts; Protamines; Resveratrol; Small Molecule Libraries; Spirostans; Stilbenes; Survival Analysis; Tumor Burden; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2015 |
Resveratrol sensitizes glioblastoma-initiating cells to temozolomide by inducing cell apoptosis and promoting differentiation.
Topics: Apoptosis; Ataxia Telangiectasia Mutated Proteins; Brain Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Neoplastic Stem Cells; Phosphorylation; Resveratrol; Signal Transduction; Stilbenes; Temozolomide; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2016 |
Resveratrol Induces Glioma Cell Apoptosis through Activation of Tristetraprolin.
Topics: 3' Untranslated Regions; Apoptosis; AU Rich Elements; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Fibroblasts; Gene Expression Regulation; Glioma; Humans; Receptors, Urokinase Plasminogen Activator; Resveratrol; RNA Stability; RNA, Messenger; Stilbenes; Tristetraprolin; Up-Regulation; Urokinase-Type Plasminogen Activator | 2015 |
Pharmacokinetics, biodistribution, in vitro cytotoxicity and biocompatibility of Vitamin E TPGS coated trans resveratrol liposomes.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Drug Carriers; Liposomes; Male; Nanomedicine; Polyethylene Glycols; Rats; Resveratrol; Stilbenes; Vitamin E | 2016 |
Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Female; Glioblastoma; Humans; Male; Mice; Mice, Inbred BALB C; Resveratrol; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2017 |
Resveratrol Impairs Glioma Stem Cells Proliferation and Motility by Modulating the Wnt Signaling Pathway.
Topics: beta Catenin; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Epithelial-Mesenchymal Transition; Glioma; Humans; Neoplastic Stem Cells; Proto-Oncogene Proteins c-myc; Resveratrol; Stilbenes; Wnt Signaling Pathway | 2017 |
The prosurvival role of autophagy in Resveratrol-induced cytotoxicity in human U251 glioma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coloring Agents; Glioma; Humans; Membrane Potentials; Microscopy, Fluorescence; Mitochondrial Membranes; Resveratrol; Stilbenes; Tetrazolium Salts; Thiazoles | 2009 |
Resveratrol induces DNA double-strand breaks through human topoisomerase II interaction.
Topics: Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; DNA Breaks, Double-Stranded; DNA Topoisomerases, Type II; DNA-Binding Proteins; Dose-Response Relationship, Drug; Glioma; Histones; Humans; Phosphorylation; Resveratrol; Stilbenes; Topoisomerase II Inhibitors | 2010 |
Resveratrol represses YKL-40 expression in human glioma U87 cells.
Topics: Adipokines; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitinase-3-Like Protein 1; Culture Media; Disease-Free Survival; Gene Expression Regulation, Neoplastic; Glioma; Glycoproteins; Humans; Lectins; Prognosis; Promoter Regions, Genetic; Recurrence; Resveratrol; Stilbenes | 2010 |
Resveratrol reduces the invasive growth and promotes the acquisition of a long-lasting differentiated phenotype in human glioblastoma cells.
Topics: Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Differentiation; Cell Division; Cell Line, Tumor; Glioblastoma; Humans; Microscopy, Fluorescence; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes; Wound Healing | 2011 |
Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis.
Topics: Aged; Animals; Antineoplastic Agents, Phytogenic; Astrocytoma; Brain Neoplasms; Chemoradiotherapy; Female; Glioblastoma; Humans; Male; Mice; Mice, SCID; Middle Aged; Resveratrol; Signal Transduction; STAT3 Transcription Factor; Stilbenes; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2012 |
Notch-1 activation-dependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Astrocytes; bcl-2-Associated X Protein; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Genes, p53; Glioblastoma; Humans; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Receptor, Notch1; Resveratrol; Signal Transduction; Stilbenes; Tumor Suppressor Protein p53 | 2011 |
Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Dacarbazine; Drug Synergism; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; Glioma; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Reactive Oxygen Species; Resveratrol; Stilbenes; Temozolomide; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |
Distinct sulfonation activities in resveratrol-sensitive and resveratrol-insensitive human glioblastoma cells.
Topics: Antineoplastic Agents, Phytogenic; Arylsulfotransferase; Blotting, Western; Brain Neoplasms; Chromatography, High Pressure Liquid; Drug Resistance, Neoplasm; Flow Cytometry; Glioblastoma; Humans; Immunoenzyme Techniques; Mass Spectrometry; Neoplasm Grading; Real-Time Polymerase Chain Reaction; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes; Sulfonic Acids; Sulfotransferases; Tissue Array Analysis; Tumor Cells, Cultured | 2012 |
Induction of neutral endopeptidase and angiotensin-converting enzyme activity of SK-N-SH cells in vitro by quercetin and resveratrol.
Topics: Angiotensin-Converting Enzyme Inhibitors; Brain Neoplasms; Cell Count; Cell Division; Cell Line; Enzyme Induction; Enzyme Inhibitors; Humans; Kinetics; Neprilysin; Neuroblastoma; Peptidyl-Dipeptidase A; Protease Inhibitors; Quercetin; Resveratrol; Stilbenes; Tumor Cells, Cultured; Wine | 2002 |
Effect of trans-resveratrol on signal transduction pathways involved in paclitaxel-induced apoptosis in human neuroblastoma SH-SY5Y cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Brain Neoplasms; Caspase 7; Caspases; Cell Death; Cell Line; DNA; Humans; Immunoblotting; Mitogen-Activated Protein Kinases; Neuroblastoma; Paclitaxel; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-raf; Resveratrol; Signal Transduction; Stilbenes; Tumor Cells, Cultured | 2003 |
Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol.
Topics: Anticarcinogenic Agents; Apoptosis; Apoptosis Regulatory Proteins; Base Sequence; Brain Neoplasms; Breast Neoplasms; Caspase Inhibitors; Caspases; Cell Cycle; Cell Division; Cell Line, Tumor; Cysteine Proteinase Inhibitors; DNA Primers; Female; Humans; Male; Melanoma; Membrane Glycoproteins; Pancreatic Neoplasms; Prostatic Neoplasms; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha | 2004 |
Resveratrol interference with the cell cycle protects human neuroblastoma SH-SY5Y cell from paclitaxel-induced apoptosis.
Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Brain Neoplasms; Cell Cycle; Cell Division; Cell Line, Tumor; Cyclin B; Cyclin B1; Cyclins; Flow Cytometry; G2 Phase; Humans; Immunoblotting; Maturation-Promoting Factor; Mitosis; Neuroblastoma; Paclitaxel; Resveratrol; Stilbenes | 2005 |
c-Myc downregulation: a critical molecular event in resveratrol-induced cell cycle arrest and apoptosis of human medulloblastoma cells.
Topics: Antioxidants; Apoptosis; Blotting, Western; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Survival; Down-Regulation; Flow Cytometry; Fluorescent Antibody Technique; Genes, myc; Humans; Immunohistochemistry; Medulloblastoma; Neoplasm Proteins; Oligonucleotides, Antisense; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; S Phase; Stilbenes; Transfection | 2006 |
Resveratrol inhibits cell growth and induces apoptosis of rat C6 glioma cells.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Blotting, Western; Brain Neoplasms; Caspase 3; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Fibroblasts; Flow Cytometry; Glioma; In Situ Nick-End Labeling; Mice; Rats; Resveratrol; Stilbenes | 2007 |
Resveratrol is pro-apoptotic and thyroid hormone is anti-apoptotic in glioma cells: both actions are integrin and ERK mediated.
Topics: Apoptosis; Brain Neoplasms; Cyclooxygenase 2; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Glioma; Humans; Integrin alphaVbeta3; Phosphorylation; Protein Kinase C; Resveratrol; Stilbenes; Thyroxine | 2008 |
Resveratrol and X rays affect gap junction intercellular communications in human glioblastoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Brain Neoplasms; Cell Communication; Cell Cycle; Cell Line, Tumor; Cell Survival; Connexin 43; Gap Junctions; Glioblastoma; Humans; Microscopy, Fluorescence; Mutation; Resveratrol; Stilbenes; X-Rays | 2008 |
Inhibition of peroxide-induced radical generation by plant polyphenols in C6 astroglioma cells.
Topics: Astrocytoma; Benzene Derivatives; Brain Neoplasms; Dose-Response Relationship, Drug; Flavonoids; Free Radical Scavengers; Free Radicals; Genistein; Luteolin; Oxidants; Oxidative Stress; Phenols; Plant Extracts; Polyphenols; Resveratrol; Stilbenes | 2008 |
Correlative analyses of notch signaling with resveratrol-induced differentiation and apoptosis of human medulloblastoma cells.
Topics: Active Transport, Cell Nucleus; Amyloid Precursor Protein Secretases; Antineoplastic Agents; Antioxidants; Apoptosis; Basic Helix-Loop-Helix Transcription Factors; Brain Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cytoplasm; Enzyme Inhibitors; Homeodomain Proteins; Humans; Medulloblastoma; Receptor, Notch1; Receptor, Notch2; Receptors, Notch; Resveratrol; Signal Transduction; Stilbenes; Transcription Factor HES-1; Up-Regulation | 2008 |